{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:50:21Z","timestamp":1792122621611,"version":"4.4.0"},"reference-count":23,"publisher":"Impact Journals, LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2016,6,22]]},"DOI":"10.18632\/aging.100983","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T20:31:10Z","timestamp":1468528270000},"page":"1593-1607","source":"Crossref","is-referenced-by-count":121,"title":["Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)"],"prefix":"10.18632","volume":"8","author":[{"given":"Marco","family":"Fiorillo","sequence":"first","affiliation":[{"name":"The Breast Cancer Now Research Unit, Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"},{"name":"The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"},{"name":"The Department of Pharmacy, Health and Nutritional Sciences, The University of Calabria, Cosenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Lamb","sequence":"additional","affiliation":[{"name":"The Breast Cancer Now Research Unit, Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"},{"name":"The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert B.","family":"Tanowitz","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Cappello","sequence":"additional","affiliation":[{"name":"The Department of Pharmacy, Health and Nutritional Sciences, The University of Calabria, Cosenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubaldo E.","family":"Martinez-Outschoorn","sequence":"additional","affiliation":[{"name":"The Sidney Kimmel Cancer Center, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Sotgia","sequence":"additional","affiliation":[{"name":"School of Environment & Life Sciences, Cockcroft Building, University of Salford, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Lisanti","sequence":"additional","affiliation":[{"name":"The Breast Cancer Now Research Unit, Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"},{"name":"The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"key":"1","first-page":"60","article-title":"Stem cells in the etiology and treatment of cancer","volume":"1","author":"Rosen","year":"2006","journal-title":"Curr Opin Genet Dev"},{"key":"2","first-page":"25","article-title":"Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy","volume":"1","author":"Kuperwasser","year":"2008","journal-title":"Breast Cancer Res"},{"key":"3","first-page":"672","article-title":"Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy","volume":"10","author":"Chang","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"4","first-page":"299","article-title":"Multi-drug-resistant cells enriched from chronic myeloid leukemia cells by Doxorubicin possess tumor-initiating-cell properties","volume":"12","author":"Tan","year":"2013","journal-title":"J Pharmacol Sci"},{"key":"5","first-page":"820","article-title":"Imaging and analysis of 3D tumor spheroids enriched for a cancer stem cell phenotype","volume":"1","author":"Barsky","year":"2010","journal-title":"J Biomol Screen"},{"key":"6","first-page":"111","article-title":"A detailed mammosphere assay protocol for the quantification of breast stem cell activity","volume":"1","author":"Clarke","year":"2012","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"7","doi-asserted-by":"crossref","first-page":"11029","DOI":"10.18632\/oncotarget.2789","article-title":"Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1\/2 inhibition","volume":"5","author":"Sotgia","year":"2014","journal-title":"Oncotarget"},{"key":"8","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.18632\/oncotarget.3174","article-title":"Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease","volume":"6","author":"Lisanti","year":"2015","journal-title":"Oncotarget"},{"key":"9","first-page":"14777","article-title":"Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells","author":"Sotgia","year":"2015","journal-title":"Oncotarget"},{"key":"10","first-page":"590","article-title":"MYC\/PGC-1alpha Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells","volume":"2","author":"Heeschen","year":"2015","journal-title":"Cell Metab"},{"key":"11","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/cddis.2015.263","article-title":"Early effects of the antineoplastic agent salinomycin on mitochondrial function","volume":"6","author":"Szabo","year":"2015","journal-title":"Cell Death Dis"},{"key":"12","first-page":"14252","article-title":"Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases","volume":"10","author":"Borrebaeck","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"13","first-page":"223","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"30","author":"Truffot-Pernot","year":"2005","journal-title":"Science"},{"key":"14","first-page":"723","article-title":"Multidrug-resistant tuberculosis and culture conversion with bedaquiline","volume":"37","author":"Dannemann","year":"2014","journal-title":"N Engl J Med"},{"key":"15","doi-asserted-by":"crossref","first-page":"1500106","DOI":"10.1126\/sciadv.1500106","article-title":"Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline","volume":"1","author":"Meier","year":"2015","journal-title":"Sci Adv"},{"key":"16","first-page":"1290","article-title":"Selectivity of TMC207 towards mycobacterial ATP synthase compared with that towards the eukaryotic homologue","volume":"5","author":"Bald","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"17","first-page":"971","article-title":"A computational model of the inhibition of Mycobacterium tuberculosis ATPase by a new drug candidate R207910","volume":"6","author":"Andries","year":"2007","journal-title":"Proteins"},{"key":"18","first-page":"1115","article-title":"Inhibition of mitochondrial proton F0F1-ATPase\/ATP synthase by polyphenolic phytochemicals","volume":"13","author":"Ramirez","year":"2000","journal-title":"Br J Pharmacol"},{"key":"19","first-page":"622","article-title":"Biological activities of polyphenols from grapes","volume":"1","author":"Li","year":"2010","journal-title":"Int J Mol Sci"},{"key":"20","doi-asserted-by":"crossref","first-page":"14005","DOI":"10.18632\/oncotarget.4159","article-title":"Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy","volume":"6","author":"Lisanti","year":"2015","journal-title":"Oncotarget"},{"key":"21","doi-asserted-by":"crossref","first-page":"10728","DOI":"10.18632\/oncotarget.3828","article-title":"Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine hedgehog-GLI signaling in breast cancer cells","volume":"6","author":"Lisanti","year":"2015","journal-title":"Oncotarget"},{"key":"22","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.18632\/oncotarget.3348","article-title":"Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via \u201cdifferentiation-based nano-therapy\u201d","volume":"6","author":"Lisanti","year":"2015","journal-title":"Oncotarget"},{"key":"23","first-page":"725","article-title":"An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients","volume":"12","author":"Szallasi","year":"2010","journal-title":"Breast cancer research and treatment"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.100983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T16:20:24Z","timestamp":1599063624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.100983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8,31]]}},"alternative-id":["100983","27344270"],"URL":"https:\/\/doi.org\/10.18632\/aging.100983","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,22]]}}}